Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Incidence and clinical features of the quinidine-associated long-QT syndrome.Am Heart J. 1986; 111: 1088-1093
- Proarrhythmia in patients treated for atrial fibrillation or atrial flutter.Ann Intern Med. 1992; 117: 141-150
- Antiarrhythmic therapy drug therapy and cardiac mortality in atrial fibrillation.J Am Coll Cardiol. 1992; 29: 527-532
- Amiodarone-associated proarrhythmic effects. A review with special reference to Torsade de Pointes tachycardia.An Intern Med. 1994; 121: 529-535
- Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.Ann Intern Med. 1997; 127: 281-284
- ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation.Circulation. 2001; 104: 2118-2150
Zimetbaum P, Pinto D, Josephson M. Inpatient or outpatient initiation of antiarrhythmic medications. Why the controversy? Heart Dis 2001;3:148–151
- Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation.Am J Cardiol. 1999; 83: 450-452
- Population pharmacokinetics of intravenous amiodarone and comparision with two-stage pharmacokinetic analysis.J Clin Pharmacol. 1997; 37: 610-617
- Population pharmacokinetics of long-term oral amiodarone therapy.Clin Pharmacol Ther. 2000; 67: 642-652
- Amiodarone to prevent recurrence of atrial fibrillation.N Engl J Med. 2000; 342: 913-920
- Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation.Am J Cardiol. 2003; 91: 81-83
☆Dr. Hauser is a Fellow in the Clinical Investigator Training Program, Beth Israel Deaconess Medical Center–Harvard/MIT Health Sciences and Technology, which is supported by Pfizer, Inc., New York, New York.